Diabetes Medication Assistance Service Stage 1: Impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes

Diabetic Medicine

Volumn 28, Issue 8, 2011, Pages 987-993

  Krass, I ^a   Mitchell, B ^a   Song, Y J C ^a   Stewart, K ^b   Peterson, G ^c   Hughes, J ^d   Smith, L ^a   White, L ^a   Armour, C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

Author keywords

Cardiovascular risk; Community pharmacy; HbA1c; Self management support; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; STATIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENVIRONMENTAL SUSTAINABILITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHARMACY; PHYSICAL ACTIVITY; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SMOKING; SOCIAL CARE; SYSTOLIC BLOOD PRESSURE;

AUSTRALIA; BLOOD GLUCOSE; COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE;

EID: 79960259697     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03296.x     Document Type: Article

References (26)

1. IDF. Diabetes Atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009. Available at Last accessed 10 September 2010.
2. WHO. Global Strategy on Diet, Physical Activity and Health. Geneva: World Health Organization, 2004. Available at Last accessed 09 September 2010.
3. Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Medicine 1993; 329: 977-986.
4. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998; 352: 837-853.
5. UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS35): prospective observational study. Br Med J 2000; 321: 405-412.
6. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS37). Diabetes Care 1999; 22: 1125-1136.
7. Jordan JE, Briggs AM, Brand CA, Osborne RH. Enhancing patient engagement in chronic disease self-management support initiatives in Australia: the need for an integrated approach. Med J Aust 2008; 189: S9-S13.
8. Dennis SM, Zwar N, Griffiths R, Roland M, Hasan I, Davies GP et al. Chronic disease management in primary care: from evidence to policy. Med J Aust 2008; 188: S53-S56.
9. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000; 15: 137-142.
10. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HGJ. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002; 22: 1294-1300.
11. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30: 238-243.
12. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc 2009; 49: 383-391.
13. Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother 2009; 43: 882-889.
14. Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists' diabetes care services. J Am Pharm Assoc 2004; 44: 455-466.
15. Berringer R, Shibley MC, Cary CC, Pugh CB, Powers PA, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 1999; 39: 791-797.
16. Clifford RM, Batty KT, Davis WA, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes - The Fremantle Diabetes Study. Diabetes Care 2005; 28: 771-776.
17. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003; 43: 173-184.
18. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med 2007; 24: 677-683.
19. Pharmacy Diabetes Care Program. Final Report. 2005. Available at Last accessed 13 September 2010.
20. National Cholesterol Education Program. Estimate of 10-year risk for coronary heart disease Framingham Point Scores. Available at Last accessed 10 September 2010.
21. Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the study of cardiovascular risk intervention by pharmacists (SCRIP). Pharmacotherapy 2004; 24: 389-394.
22. McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MA, Jones CA et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 2008; 168: 2355-2361.
23. AHA. Heart Disease and Stroke Statistics - 2010 Update. Dallas: American Heart Association, 2010.
24. Allender S, Peto V, Scarborough P, Kaur A, Rayner M. Coronary Heart Disease Statistics 2008, 16th edn. London: British Heart Foundation, 2008.
25. WHOSIS. Mortality Country Fact Sheets. Geneva: World Health Organisation Statistical Information System, 2006. Available at Last accessed 10 September 2010.
26. Australian Bureau of Statistics. Causes of Death Australia 2008. Catologue no.3303.0. Available at Last accessed 10 September 2010.